EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt–Jakob Disease MV1 Subtype

Satish K Nemani, Leonardo M Cortez, Jennifer Myskiw, Ignazio Cali, Stephanie A Booth, Gerard H Jansen, Valerie L Sim iD

Neuropathology and Applied Neurobiology · 2026-06 · 52 (3)

DOI: 10.1111/nan.70078 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 05.05.2026. Verfasst von Satish K Nemani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, Brain. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Creutzfeldt-Jakob Disease Foundation, Alberta Innovates, Thompson family (in memory of Marilyn Thompson).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MV1 subtype of sporadic Creutzfeldt–Jakob disease (sCJD) is one of the least studied. Cases are defined by the presence of the methionine/valine (MV) polymorphism at codon 129 of the PRNP gene and a type 1 immunoblot pattern of pathological prion protein (PrP D ), where the unglycosylated PrP D fragment migrates at ~21 kDa (T 21 ). Because the originally described MV1 cases had T 21 plus brain pathology indistinguishable from MM1 cases (small vacuoles), the MV1 subtype has historically been grouped with MM1. However, the recent identification of MV1 cases with immunoblot and pathological features similar to the VV1 subtype (T 21–20 doublet, larger vacuoles, ballooned neurons) has raised the possibility that the MV1 subtype is more heterogeneous than originally proposed. Here, we report three MV1 cases that further reveal the heterogeneity of this subtype. All cases were atypical in that they had persistent T 20 fragments, in isolation or combination with T 21 or T 19 , when typed at pH 6.9, a finding that would have been missed if typing were undertaken at pH 8.0 only. Fragment proportions differed in different brain regions, and further examination found that the cases had mixed MM1/VV1 features, predominant VV1‐like characteristics or features of the MV2C subtype. Two cases had small to intermediate‐sized vacuoles and synaptic PrP staining. The third case had intermediate vacuolation, weak synaptic staining and coarse PrP deposits. We also describe, for the first time, the application of asymmetric‐flow field‐flow fractionation as a novel tool to discriminate sCJD subtypes based on size distributions of protease‐resistant and protease‐sensitive PrP D . Overall, we propose that MV1 is a more heterogeneous subtype than previously appreciated, potentially existing along a spectrum from MM1‐like to VV1‐like phenotypes. Importantly, this biochemical heterogeneity may be underrepresented when subtyping is done at pH 8.0, so we recommend CJD subtyping be performed at pH 6.9 to avoid missing atypical or mixed cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Creutzfeldt-Jakob SyndromeBrainHumansPhenotypeMaleFemaleAgedPrion ProteinsPrionsValineMethionineMiddle Aged

Stichwörter der Autor:innen

Creutzfeldt–Jakob disease (CJD)neuropathologyphenotypeprion diseaseprotein conformationstrain typing

Substanzen

Prion ProteinsPrionsValineMethionine

Autor:innen und Institutionen

  • Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Mycobacteriology, Vector-Borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
  • National Prion Disease Pathology Surveillance Center, Cleveland, Ohio, USA.
  • Faculty of Medicine and Surgery, 'Kore' University of Enna, Enna, Italy.

ORCID-Profile: Valerie L Sim

Förderung

  • Creutzfeldt-Jakob Disease Foundation
  • Alberta Innovates
  • Thompson family (in memory of Marilyn Thompson)
  • Scully family and friends (in memory of Rick Scully)
  • Lauman family and friends (in memory of Sabrina Lauman)

Zitieren

APA

Nemani, S. K., Cortez, L. M., Myskiw, J., Cali, I., Booth, S. A., Jansen, G. H., & Sim, V. L. (2026). Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt–Jakob Disease MV1 Subtype. Neuropathology and Applied Neurobiology, 52(3). https://doi.org/10.1111/nan.70078

Vancouver

Nemani SK, Cortez LM, Myskiw J, Cali I, Booth SA, Jansen GH, et al. Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt–Jakob Disease MV1 Subtype. Neuropathology and Applied Neurobiology. 2026;52(3). doi:10.1111/nan.70078

BibTeX
@article{Nemani2026,
  author = {Nemani, Satish K and Cortez, Leonardo M and Myskiw, Jennifer and Cali, Ignazio and Booth, Stephanie A and Jansen, Gerard H and Sim, Valerie L},
  title = {Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt–Jakob Disease MV1 Subtype},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2026},
  volume = {52},
  number = {3},
  doi = {10.1111/nan.70078}
}
Kostenlos starten →